| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 4 | -472K | 100% | $40.85 | -$19.3M |
| Net | -4 | -472K | -100% | -$19.3M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Yujiro Hata | President and CEO, Director | $28.7M | -$17.6M | -37.9% | May 14, 2024 |
| Michael P. Dillon | SVP, Chief Scientific Officer | $3.31M | Oct 4, 2021 | ||
| Andres Ruiz | Title: SVP, Head of Finance and Investor Relations | $1.13M | -$320K | -22.1% | Mar 1, 2024 |
| Jason Throne | Chief Legal Officer | $445K | -$350K | -44% | Jun 27, 2024 |
| Paul A. Stone | Chief Financial Officer | $391K | Aug 29, 2023 | ||
| Michael Anthony White | Chief Scientific Officer | $0 | -$1.03M | -100% | May 29, 2024 |
| Wendy L. Yarno | Director | May 31, 2024 | |||
| Timothy M. Shannon | Director | Jun 7, 2023 | |||
| Susan L. Kelley | Director | May 31, 2024 | |||
| Malcolm Garret Hampton | Director | May 31, 2024 | |||
| Terry J. Rosen | Director | May 31, 2024 | |||
| Douglas B. Snyder | SVP, General Counsel | Sep 26, 2024 | |||
| Jeffrey Stein | Director | May 31, 2024 | |||
| Catherine J. Mackey | Director | May 31, 2024 | |||
| Darrin Beaupre | Chief Medical Officer | Mar 1, 2024 | |||
| Scott W. Morrison | Director | May 31, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|